Loading...

AVBP ARRIVENT BIOPHARMA INC Management Changes 8-K Filing

RRVN

VBP

ARRIVENT BIOPHARMA INC

(AVBP)

2025 8-K

Stock Offering Update

Financial Results Released

Presentation Announcement

Financial Results Report

Financial Results Announcement

Data Presentation

Product Expansion

Equity Offerings

Product Expansion

Financial Statements

Accounting Firm Change

Financial Results

License Agreement

Q3 Financial Results

Positive Trial Results

External Links:

On April 23, 2025, Dr. Carl Gordon announced he would not seek re-election to the Board of ArriVent BioPharma, leading to the appointment of Dr. Merdad Parsey as a new director. The Board increased its size from 7 to 8 members to accommodate this change, with additional details about Dr. Parsey's compensation included.

AI Assistant

ARRIVENT BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.